Valitacell
ValitaCell is a Dublin-based biotechnology company that develops fluorescence polarization-based IgG quantification assays (Valita Titer) for rapid biologics drug development, sold exclusively through parent Beckman Coulter Life Sciences.
- Company typePrivate
- Founded2014
- HeadquartersDublin, Ireland
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Valitacell does
ValitaCell Ltd is a Dublin-based biotechnology company founded in 2014 that develops plate-based fluorescence polarization assays for rapid quantification of IgG antibodies directly from cell culture samples. Its core product line, branded Valita Titer, comprises 96-well and 384-well assays covering two IgG concentration ranges (2.5-100 mg/L and 100-2000 mg/L), engineered to deliver titer results in under 15 minutes without sample preparation, wash steps, or additional reagents. A companion line, Valita Aggregation Pure, addresses protein aggregation measurement, and the two product families are positioned to be bundled with Agilent BioTek multimode microplate readers for an integrated titer-plus-aggregation workflow. All products are labeled "For Research Use Only."
The company's commercial model is built on consumable kit sales with publicly listed unit pricing ($6,782 to $27,128 per kit) and quote-based pricing for the high-titer 384-well SKU. ValitaCell operates as a wholly-owned subsidiary of Beckman Coulter Life Sciences — itself a Danaher Corporation company — and sells exclusively through Beckman Coulter's global direct-sales force, e-commerce storefront, and inside-sales quote channel. The end customer base spans biopharmaceutical companies developing monoclonal antibody therapeutics, process development laboratories optimizing bioprocesses, and analytical development teams performing titer verification during biologics drug development. Headcount is reported at 1-10 employees, and the company functions primarily as a focused product-line entity within Danaher's life sciences portfolio rather than as an independent scaling startup.
Operationally, ValitaCell's differentiation centers on workflow compression (15-minute results vs. hours for ELISA/HPLC), precision (<2.5% RSD) and accuracy (>95%) specifications, and demonstrated automation compatibility on Beckman Biomek liquid handling workstations. The combined footprint of Beckman Coulter distribution and Danaher-level corporate backing positions Valita Titer as a branded reagent line rather than a venture-backed growth equity story.
Valitacell firmographics
Firmographics- Name
- Valitacell
- Legal name
- ValitaCell Ltd
- Website
- https://valitacell.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ValitaCell is a Dublin-based biotechnology company that develops fluorescence polarization-based IgG quantification assays (Valita Titer) for rapid biologics drug development, sold exclusively through parent Beckman Coulter Life Sciences.
- Ownership category
- akta.pro rank
Valitacell industry classification
Industry- Product category
- Biologics Analytics Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB)
Keywords
Where Valitacell is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- Ireland
- HQ region
- Europe
Markets served
Valitacell business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Assay Kit Sales: Sale of Valita Titer IgG quantification assay kits in 96-well and 384-well plate formats. Products include VAL003 (2.5-100 mg/L, 96-well at $6,782), VAL004 (100-2000 mg/L, 96-well at $8,975), VAL013 (2.5-100 mg/L, 384-well at $27,128), and VAL014 (100-2000 mg/L, 384-well).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Valita Titer IgG Quantification Assay 96-well (2.5 - 100 mg/L) - VAL003 |
| Unit Pricing | Pay-as-you-go | Valita Titer IgG Quantification Assay 96-well (100 - 2000 mg/L) - VAL004 |
| Unit Pricing | Pay-as-you-go | Valita Titer IgG Quantification Assay 384-well (2.5 - 100 mg/L) - VAL013 |
| Unit Pricing | Pay-as-you-go | Valita Titer IgG Quantification Assay 384-well (100 - 2000 mg/L) - VAL014 |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Valitacell product offering
Product offeringCore offering
ValitaCell develops and sells plate-based fluorescence polarization assay kits that quantify IgG antibodies directly from cell suspension without sample preparation, delivering results in under 15 minutes for biopharmaceutical clone screening, cell line development, and process optimization workflows. Its portfolio includes Valita Titer assays in 96-well and 384-well formats across low and high IgG concentration ranges, plus Valita Aggregation Pure kits for protein aggregation measurement, distributed exclusively through Beckman Coulter Life Sciences.
Product overview
ValitaCell (a Beckman Coulter company) offers a portfolio of plate-based fluorescence polarization assays for rapid IgG quantification in biologics drug discovery and development. The core product line consists of Valita Titer Assays available in 96-well and 384-well formats, each offered in two IgG concentration ranges (2.5-100 mg/L and 100-2000 mg/L). These assays measure IgG directly in cell suspension without sample preparation, providing results in under 15 minutes. Valita Aggregation Pure Assay Kits complement the titer assays for protein aggregation measurement. The complete solution can be bundled with Agilent BioTek multimode microplate readers for integrated protein titer and aggregation measurement workflows.
Differentiator
Problem solved
Functional benefit
Brands
- Valita Titer: Plate-based, 96- and 384-well assays for rapid, cost-effective IgG quantification using fluorescence polarization technology. Valita Titer is among the industry's fastest IgG tests.
- Valita Aggregation Pure
Products and services
- Valita Titer IgG Quantification Assay 96-well (2.5 - 100 mg/L) Plate-based 96-well fluorescence polarization assay for rapid IgG quantification directly from cell suspension, covering the 2.5-100 mg/L concentration range, with results in under 15 minutes; targeted at biopharmaceutical clone screening and cell line development workflows.
- Valita Titer IgG Quantification Assay 96-well (100 - 2000 mg/L) Plate-based 96-well fluorescence polarization assay for rapid IgG quantification directly from cell suspension, covering the 100-2000 mg/L high-titer concentration range, with results in under 15 minutes; intended for high-titer bioprocess samples.
- Valita Titer IgG Quantification Assay 384-well (2.5 - 100 mg/L) High-throughput 384-well fluorescence polarization assay for rapid IgG quantification, covering the 2.5-100 mg/L concentration range, enabling increased throughput for clone screening during drug discovery and development.
- Valita Titer IgG Quantification Assay 384-well (100 - 2000 mg/L) High-throughput 384-well fluorescence polarization assay for rapid IgG quantification, covering the 100-2000 mg/L high-titer concentration range, designed for high-titer samples in scaled-up clone screening workflows.
- Valita Aggregation Pure Assay Kits Companion assay kits for protein aggregation measurement that, when bundled with Valita Titer assays and Agilent BioTek multimode microplate readers, enable a complete sub-15-minute protein titer and aggregation measurement workflow for biologics analytics.
Quantifiable outcome
- Results in less than 15 minutes (vs hours for ELISA/HPLC)
- +4 more outcomes
Companies that use Valitacell
Customer profileSegments3 records
Ideal customer profiles2 records
Valitacell technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Valitacell partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Beckman Coulter Life SciencescoreBeckman Coulter Life Sciences serves as the exclusive global distributor for ValitaCell products including Valita Titer IgG quantification assays and Valita Aggregation Pure assay kits. The products are integrated into Beckman Coulter's reagent portfolio and sold through their global sales network, e-commerce platform, and distribution channels. ValitaCell is identified as a Beckman Coulter Company, indicating a close distribution and ownership relationship.
Recent moves5 records
Expansion highlights4 records
Valitacell competitors and assessment
Company assessmentBroad incumbents
- Bio-Rad Laboratories: Bio-Rad offers Bio-Plex and ProA-based assays for IgG quantification in biologics workflows. As a broad incumbent in life science research, it competes with ValitaCell in clone screening and titer measurement within the same biopharma customer base.
- Cytiva: Cytiva supplies Protein A affinity columns and related titer measurement workflows for mAb manufacturing. It operates as a broad bioprocess incumbent whose analytics and consumables overlap with ValitaCell's cell line development focus.
- Thermo Fisher Scientific: Thermo Fisher offers ELISA kits, Protein A binding assays, and automated platforms for IgG titer across its life sciences portfolio. As a broad incumbent, it competes for the same biopharma analytics budgets ValitaCell targets via Beckman Coulter.
- Merck KGaA / MilliporeSigma: MilliporeSigma supplies ELISA-based titer assays and Prozain A / Protein A affinity products for clone screening in mAb development. As a broad life science tools incumbent, it competes for the same IgG quantification dollars.
Direct peers
- Repligen: Repligen sells the CTG (Cell Titer-Glo) and Protein A titer measurement systems used in bioprocess development. It directly competes with Valita Titer for rapid IgG quantification in cell line development, and is a similarly specialized life science tools provider for biologics.
- Sartorius (ForteBio): ForteBio (now part of Sartorius) markets Octet BLI-based biosensors for rapid, label-free protein quantification including IgG titer. It targets the same clone screening and bioprocess development use cases as ValitaCell and is the most cited direct competitor on speed/throughput.
- Pall Corporation (Danaher): Pall offers the Octet and other BLI-based systems (alongside other analytics) for rapid protein titer measurement; it is also a Danaher company, making it a direct intra-portfolio peer to ValitaCell with overlapping mAb workflow offerings.
Emerging players
- Agilent Technologies: Agilent's BioTek line of multimode microplate readers is the instrument layer paired with Valita Titer assays. Agilent is adjacent/partnering rather than directly competing, but its instrumentation underpins the throughput positioning of ValitaCell's 384-well assays.
- PerkinElmer: PerkinElmer offers AlphaLISA and other homogeneous immunoassays for rapid IgG quantification in high-throughput formats. It overlaps with ValitaCell's plate-based, no-wash assay approach and is positioned as a competing rapid titer solution.
Others
- Yokogawa / Sysmex (Cell Line Development Tools): Providers of clone screening workstations and analytics for cell line development that integrate with rapid IgG titer assays. Included as ecosystem participants adjacent to ValitaCell's core assay workflow.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Valitacell social profiles
Digital presenceValitacell compliance and trust
Trust signalCompliance1 record
Valitacell financial estimates
Financial estimateRevenue estimate
Valuation estimate
Valitacell leadership team
Management profileNumber of profiles
Profiles1 record
Valitacell funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Valitacell M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Valitacell
What does Valitacell do?
ValitaCell develops and sells plate-based fluorescence polarization assay kits that quantify IgG antibodies directly from cell suspension without sample preparation, delivering results in under 15 minutes for biopharmaceutical clone screening, cell line development, and process optimization workflows. Its portfolio includes Valita Titer assays in 96-well and 384-well formats across low and high IgG concentration ranges, plus Valita Aggregation Pure kits for protein aggregation measurement, distributed exclusively through Beckman Coulter Life Sciences.
Is Valitacell a public or private company?
Valitacell is a private company. It is classified as corporate owned and is currently operating.
When was Valitacell founded?
Valitacell was founded in 2014. It employs 1 to 10 people.
Where is Valitacell based?
Valitacell is headquartered in Dublin, Ireland, in the Europe region.
How does Valitacell make money?
One revenue line is on record: assay Kit Sales.
Who are Valitacell's main competitors?
Broad incumbents on record are Bio-Rad Laboratories, Cytiva, Thermo Fisher Scientific and Merck KGaA / MilliporeSigma. Direct peers are Repligen, Sartorius (ForteBio) and Pall Corporation (Danaher). Emerging players are Agilent Technologies and PerkinElmer. Yokogawa / Sysmex (Cell Line Development Tools) is listed as an others.
Does Valitacell have an API?
No public API is recorded for Valitacell.
What industry is Valitacell in?
Valitacell's product category is Biologics Analytics Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAIAA, High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening). Its NAICS code is 325413 and its SIC code is 2835.